Relay
is a Massachusetts-based precision medicine company that provides drug discovery solutions for sectors including biotechnology and pharmaceutical... Read moreRelay
is a Massachusetts-based precision medicine company that provides drug discovery solutions for sectors including biotechnology and pharmaceutical... Read more
News
Apr 06, 2026
Seeking Alpha
Relay: Relay Therapeutics, Inc. (RLAY) Discusses Mutant Selective PI3K-alpha Inhibitor for PIK3CA-Driven Vascular Anomalies - Slideshow
Apr 02, 2026
Benzinga
Relay: Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Mar 19, 2026
Nasdaq
Relay: Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.
Mar 16, 2026
GlobalNewswire
Press Release: Relay : Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
Mar 16, 2026
Benzinga
Relay: Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival
Mar 11, 2026
Seeking Alpha
Relay: Relay Therapeutics, Inc. (RLAY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Mar 09, 2026
Owler
Relay Therapeutics, Inc.: Relay's employee count changed from 365 in Dec 2024 to 192 in Dec 2025
Mar 05, 2026
Seeking Alpha
Relay: Relay Therapeutics: Breakthrough Designation Sets The Stage For A Key Zovegalisib Data Catalyst
Feb 28, 2026
Yahoo
Relay: Relay Therapeutics (RLAY) Valuation After Breakthrough Therapy Win And Narrower Loss Attracts Fresh Investor Interest
Feb 27, 2026
Owler
Relay Therapeutics, Inc.: Relay's revenue changed from $8.36M in Sep 2025 to $15.36M in Dec 2025
Relay Competitors
1
2
3
4
5
6
7
8
9
10